
Technology is transforming surgical care through advances that have enabled greater miniaturization, enhanced precision, and improved patient outcomes. Minimally invasive surgery has been at the forefront of this evolution, with robotic platforms facilitating increasingly complex procedures through superior visualization, enhanced dexterity, and improved surgeon ergonomics. Artificial intelligence is augmenting intraoperative decision-making, patient monitoring, and clinical documentation. Augmented reality has the potential to improve patient safety by enhancing anatomic navigation and reducing technical errors, but its widespread adoption remains limited by challenges such as registration drift and system latency. Virtual reality has emerged as a valuable tool for surgical education and simulation, helping to shorten the learning curve and reduce procedure-related complications. Ambient listening technologies offer opportunities to improve clinical documentation and workflow efficiency, whereas teleoperated surgery has the potential to expand access to specialist surgical expertise beyond geographical constraints. Despite these advances, important barriers to implementation remain. Cost, infrastructure requirements, regulatory considerations, and the need for robust evidence demonstrating meaningful clinical benefit and cost-effectiveness will ultimately determine the value and adoption of emerging technologies. As surgery continues to evolve, surgeons must develop not only technical proficiency and adaptability but also digital literacy, critical appraisal skills, and an understanding of data-driven health care. Ethical practice, patient safety, and strong clinical governance must remain central to the integration of technological innovation into surgical care.
Background Risk-adapted de-escalation in sporadic medullary thyroid carcinoma requires identification of patients in whom lymph-node dissection and thyroid preservation can be safely modulated. Desmoplastic stromal reaction predicts nodal metastases, but whether desmoplastic stromal reaction, nodal status, and multifocality can be integrated into a staged clinical decision framework remains unclear. Methods This retrospective cohort study included adults with sporadic medullary thyroid carcinoma undergoing index surgery between January 2018 and March 2026 at a referral endocrine surgery center. Factors associated with lymph node metastases, multifocality, and the pN0-unifocal phenotype were assessed using univariable analyses and exploratory machine-learning models. Results Among 331 patients operated for medullary thyroid carcinoma, 94 met inclusion criteria. Lymph node metastases were present in 29 patients (30.9%). All node-positive tumors were desmoplastic stromal reaction positive, whereas no desmoplastic stromal reaction—negative tumor had lymph node metastases (P < .001). Lymph node metastases were also associated with higher basal calcitonin and carcinoembryonic antigen, larger tumor diameter, male sex, advanced pT category, high-grade medullary thyroid carcinoma, extrathyroidal extension, vascular invasion, and multifocality. Multifocality occurred in 14 patients (14.9%) and was associated with male sex, advanced pT category, lymph node metastases, and extrathyroidal extension. The pN0-unifocal phenotype was associated with female sex, lower biochemical markers, absence of desmoplastic stromal reaction, smaller tumor diameter, absence of extrathyroidal extension, and absence of vascular invasion. Conclusion Desmoplastic stromal reaction negativity identifies negligible nodal risk but does not exclude occult contralateral disease. We propose a staged clinical decision framework integrating preoperative selection with intraoperative pathologic assessment to explore thyroid preservation in highly selected patients. This framework is hypothesis generating and requires prospective validation.
Background Obesity is associated with worse outcomes after open and laparoscopic liver resection, but its independent contribution after robotic liver resection has not been formally interrogated in a large cohort. This study aims to determine whether body mass index predicts textbook outcome after robotic liver resection. Methods Consecutive adult patients undergoing robotic liver resection at 30 international high-volume benchmark centers (2020–2023) were analyzed. Living donor hepatectomies were excluded from the primary analysis. The primary outcome was textbook outcome. Generalized estimating equations with center as the cluster provided cluster-robust standard errors for all multivariable models. Sensitivity analyses reincluded living donors, applied Asia-Pacific body mass index cut points, and restricted to high-contributing centers. Results Among 2,905 nondonor patients (normal: 1,263; overweight: 1,007; obese: 427; and morbidly obese: 208) across 29 centers, the overall non–textbook outcome rate was 22.0% and differed little across body mass index strata unadjusted (19.6%, 24.2%, 23.0%, and 23.6%; P = .05). Center-level variation was substantial. After adjustment, body mass index was not an independent predictor (per 1 kg/m2, odds ratio, 1.00; 95% confidence interval, 0.98–1.02; P = .81; morbidly obese versus normal: odds ratio, 1.01; 95% confidence interval, 0.68–1.51; P = .96), and adding body mass index to the multivariable model left discrimination unchanged (area under the curve, 0.699 with and without body mass index). Dominant determinants of non–textbook outcome were malignant indication (odds ratio, 2.45, 1.70–3.52; P < .001), major hepatectomy (odds ratio, 1.57, 1.24–1.97; P < .001), and neoadjuvant therapy (odds ratio, 1.36; 1.13–1.63; P = .001). Higher body mass index showed a nonsignificant trend toward increased surgical site infection (odds ratio per 5 kg/m2, 1.18, 0.99–1.41; P = .06) but no association with major complications. Findings were robust across all sensitivity analyses, including reinclusion of the 1,180 living donors. No body mass index × IWATE interaction was detected (P = .82). Conclusion Among patients selected for robotic liver resection at experienced centers, body mass index was not an independent determinant of textbook outcome or of major complications. Surgical complexity, indication, and extent of resection were the dominant drivers of perioperative outcome. These findings are conditional on a robotic approach having been offered and do not address the upstream choice between robotic, laparoscopic, and open surgery.
Background: The National Accreditation Program for Rectal Cancer, developed by the American College of Surgeons Commission on Cancer, was established to standardize and improve the quality of rectal cancer care. While prior research has focused primarily on clinical outcomes, limited evidence exists on how National Accreditation Program for Rectal Cancer accreditation affects patient volume and geographical reach in a community hospital setting. This project evaluates the impact of National Accreditation Program for Rectal Cancer accreditation on rectal cancer patient volume and the geographic distribution of patients seeking care. Study Design: Retrospective observational study conducted from July 2016 through December 2024 at a single community-based hospital. Monthly and annual rectal cancer patient volumes and patient zip codes were collected and analyzed to determine changes over time. Results: The average monthly rectal cancer patient volume increased from 1.0 patient per month pre-accreditation to 4.58 patients per month postaccreditation. However, the segmented Poisson regression did not yield a statistically significant change across all periods. The geographic catchment area expanded from 22 zip codes to 79 zip codes after accreditation. Average patient distance traveled increased by 6 miles, but the change did not reach statistical significance. Conclusion: National Accreditation Program for Rectal Cancer accreditation was associated with an increase in patient volume and a broader geographic scope of patients seeking care at a community hospital; however, this change cannot be disentangled from the hiring of 2 fellowship-trained colorectal surgeons. Accreditation may serve as a signal to patients and referring providers of high-quality, disease-specific care, potentially enhancing the institution's competitive standing and patient draw in the health care marketplace. (c) 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.